StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

Mangoceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Mangoceuticals's operating income for the twelve months ending Jun 30, 2026 was -$12.07M. For fiscal 2025 it was -$18.03M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.03M–
FY2024Dec 31, 2024-$7.97M–
FY2023Dec 31, 2023-$9.22M–
FY2022Dec 31, 2022-$1.99M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.03M–
Q1 FY2026Mar 31, 2026-$3.13M–
Q4 FY2025Dec 31, 2025-$367.74K–
Q3 FY2025Sep 30, 2025-$7.54M–
Q2 FY2025Jun 30, 2025-$5.27M–
Q1 FY2025Mar 31, 2025-$4.58M–
Q4 FY2024Dec 31, 2024-$1.68M–
Q3 FY2024Sep 30, 2024-$1.76M–
Q2 FY2024Jun 30, 2024-$2.17M–
Q1 FY2024Mar 31, 2024-$2.37M–
Q4 FY2023Dec 31, 2023-$2.57M–
Q3 FY2023Sep 30, 2023-$1.80M–
Q2 FY2023Jun 30, 2023-$2.29M–
Q1 FY2023Mar 31, 2023-$2.56M–
Q4 FY2022Dec 31, 2022-$671.86K–
Q3 FY2022Sep 30, 2022-$991.83K–
Q2 FY2022Jun 30, 2022-$327.90K–
Q1 FY2022Mar 31, 2022-$18.71K–

More Mangoceuticals figures

See a number that looks wrong?